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This indicates that, in patients with a low lymphocyte
count, the immunoassay could have a low sensitivity and give
false-negative results. Indeed, three negative QFT-IT subjects
had active TB with a CD4 cell count of 17, 95 and 19 cells/
lL, respectively.
Among QFT-IT negative subjects (CD4 cell count
>200 cells/lL), three had active TB, their CD4 cell count
was >400 cells/lL, and the percentage of lymphocytes in two
cases was >15%, whereas, in one patient, it was 10%. Thus,
it is very important to assess not only CD4 cell counts, but
also their percentage in the total population because a low
percentage may lead to false-negative results. In the two sub-
jects with a high count and a high percentage of lympho-
cytes, the negative QFT-IT response may not be a result of
HIV but, instead, active TB; several studies have been shown
that, in immunocompetent individuals with active TB, QFT-IT
has a low sensitivity [10].
Patients with active TB and negative QFT-IT (both CD4<
and >200 cells/lL) were in stage C3 of HIV infection, and
this factor may have led to the failure of the immunological
assay. As HIV infection progresses, there is a switch from
the cellular to the humoural immune response with a reduc-
tion in the production of interferon-c [11].
A limitation of the present study is the limited number
of subjects with active TB who were tested, although our
ﬁndings conﬁrm the previously published data [9]. The
results obtained in the present study indicate that the inter-
feron-c assay was affected by the CD4 cell count and per-
centage, as well as by the stage of HIV infection. It would
be very useful to establish threshold values with regard to
the CD4 parametres below which the immunoassay may
not be sensitive and give false-negative or indeterminate
results.
Transparency Declaration
The authors declare that there is no ﬁnancial involvement
with the producer of QuantiFERON-TB Gold kit used in this
study.
References
1. Chin DP, Osmond D, Page-Shafer K et al. Reliability of anergy skin
testing in persons with HIV infection. The pulmonary Complications
of HIV Infection Study Group. Am J Respir Crit Care Med 1996; 153:
1982–1984.
2. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for
the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev
Mol Diagn 2006; 6: 413–422.
3. Harada N, Higuchi K, Yoshiyama T et al. Comparison of the sensitiv-
ity and speciﬁ city of two whole blood interferon-gamma assays for
M. tuberculosis infection. J Infect 2008; 56: 348–353.
4. Katiyar SK, Sampath A, Bihari S, Mamtani M et al. Use of the
QuantiFERON-TB Gold In-Tube test to monitor treatment efﬁcacy
in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2008; 2:
1146–1152.
5. Mori T, Sakatani M, Yamagishi F et al. Speciﬁc detection of tuberculo-
sis infection: an interferon-gamma-based assay using new antigens. Am
J Respir Crit Care Med 2004; 170: 59–64.
6. Bua A, Molicotti P, Delogu G et al. QuantiFERON TB Gold: a new
method for latent tuberculosis infection. New Microbiol 2007; 30:
477–480.
7. Palazzo R, Spensieri F, Massari M et al. Use of whole-blood samples
in in-house bulk and singlecell antigen-speciﬁc gamma interferon
assays for surveillance of Mycobacterium tuberculosis infections. Clin
Vaccine Immunol 2008; 15: 327–337.
8. Mazurek GH, Zajdowicz MJ, Hankinson AL et al. Detection of Myco-
bacterium tuberculosis infection in United States Navy recruits using
the tuberculin skin test or whole-blood interferon gamma release
assays. Clin Infect Dis 2007; 45: 826–836.
9. Raby E, Moyo M, Devendra A, Banda J, De HP et al. The effects of
HIV on the sensitivity of a whole blood IFN-gamma release assay in
Zambian adults with active tuberculosis. PLoS ONE 2008; 3: e2489.
10. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-
blood interferon-gamma release assay for detection of active tuber-
culosis. Clin Infect Dis 2007; 44: 69–73.
11. Clerici M, Shearer GM. A TH1 ﬁ TH2 switch is a critical step in the
etiology of HIV infection. Immunol Today 1993; 14: 107–111. Review.
Molecular epidemiology and genetic
diversity of human astrovirus in South
Korea from 2002 to 2007
A. Y. Jeong1, H. S. Jeong1, M. Y. Jo1, S. Y. Jung1, M. S. Lee1,
J. S. Lee1*, Y. M. Jee1, J.-H. Kim2 and D.-S. Cheon1
1) Division of Enteric and Hepatitis Viruses, Center for Infectious Diseases,
National Institute of Health, Korea Centers for Disease Control and
Prevention, Seoul and 2) Department of Pediatrics, College of Medicine,
The Catholic University of Korea, St Vincent Hospital, Suwon, South Korea
Abstract
The present study was conducted to survey the prevalence and
genotypic distribution of human astrovirus (HAstV) circulating in
South Korea. Of 160,027 patients with acute gastroenteritis,
2,057 (1.3%) were positive for HAstV antigen. We determined
the genotypes of 187 HAstV strains collected from laboratories
across the country. Genetic analysis revealed genotype 1 to be
the most prevalent, accounting for 72.19% of the strains, fol-
lowed by genotypes 8 (9.63%), 6 (6.95%), 4 (6.42%), 2 (3.21%)
and 3 (1.60%). Our ﬁndings indicate that HAstV is less common
but, even so, a potentially important viral agent of gastroenteritis
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in South Korea, with signiﬁcant genetic diversity among circulat-
ing HAstV strains.
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Human astroviruses (HAstV) are recognized as a common
cause of infantile acute gastroenteritis worldwide [1]. HAstV,
along with rotaviruses and caliciviruses, are considered
important viral agents of acute gastroenteritis [2]. HAstV are
small, single-stranded RNA viruses of 28–34 nm in length,
belonging to the recently described family Astroviridae [3].
Their genome is 6.8–7.3 kb in length and contains three
overlapping open reading frames (ORFs) [4,5]. ORF1a and
ORF1b encode the nonstructural serine protease and RNA
polymerase proteins, respectively [6]. ORF2 encodes the
capsid precursor. A 348-bp segment located between nucleo-
tides 258 and 606 of full-length ORF2 has commonly been
used for genotyping HAstV in previous studies, and eight ser-
otypes of HAstV have been identiﬁed. Typing surveys indi-
cate that genotype 1 (HAstV-1) is the most prevalent,
genotypes 2–4 are common, and genotypes 5–7 are relatively
uncommon; genotype 8 has only recently been identiﬁed
[1,7–12]. The present study summarizes the results of a
6-year period of nationwide surveillance in South Korea
(hereafter referred to as ‘Korea’) conducted to determine
the epidemiological prevalence of HAstV gastroenteritis and
characterize the HAstV genotypes circulating across the
country.
The Korean Center for Disease Control and Prevention,
in collaboration with 16 laboratories of local Public Health
Institutes and more than 100 sentinel hospital participants,
initiated a viral agent surveillance system for acute gastroen-
teritis in 1999. Faecal samples submitted for investigation of
suspected acute infectious gastroenteritis and tested positive
for HAstV antigen were collected for genotyping. From January
2002 to December 2007, faecal samples from 160 027
patients with acute gastroenteritis were investigated. A total
of 2057 samples (1.3%) (detection rate per year, 0.6–2.4%)
were identiﬁed as positive for HAstV by ELISA (IDEIA
HAstV, Dako Ltd, Ely, UK).
By performing RT-PCR, we determined the genotypes of
187 HAstV strains received from multiple laboratories
around the country. The faecal samples were diluted 1:10 in
phosphate-buffered saline (pH 7.2), vortexed, and cleared by
centrifugation. Supernatants were collected and stored at
)70C until use. Total RNA was extracted from 25 lL of
supernatant samples by using TRIZOL reagent (Invitrogen,
Carlsbad, CA, USA) in accordance with the manufacturer’s
instructions. For the detection of HAstV, an RT-PCR assay
was carried out using primers Mon 269 and Mon 270 direc-
ted against the ORF2 region, as described by Noel et al.
TABLE 1. Yearly distribution of human astrovirus (HAstV) genotypes detected in cases of acute gastroenteritis in Korea, from
2002 to 2007
Genotype
Number (%) of HAstV strains of each genotype according to year
2002
(n = 12)
2003
(n = 67)
2004
(n = 55)
2005
(n = 20)
2006
(n = 15)
2007
(n = 18)
Total
(n = 187)
HastV 1 11 (91.67) 51 (76.12) 38 (69.09) 12 (60.00) 13 (86.67) 10 (55.55) 135 (72.19)
1aa 11 (91.67) 48 (71.64) 38 (69.09) 12 (60.00) 8 (53.33) 6 (33.33) 123 (65.78)
1b 0 (0) 2 (2.99) 0 (0) 0 (0) 1 (6.67) 2 (11.11) 5 (2.67)
1d 0 (0) 1 (1.49) 0 (0) 0 (0) 4 (26.67) 2 (11.11) 7 (3.74)
HAstV 2 (2a) 1 (8.33) 3 (4.48) 0 (0) 0 (0) 0 (0) 2 (11.11) 6 (3.21)
HAstV 3 0 (0) 0 (0) 0 (0) 0 (0) 1 (6.67) 2 (11.11) 3 (1.60)
HAstV 4 (4a) 0 (0) 3 (4.48) 8 (14.55) 1 (5.00) 0 (0) 0 (0) 12 (6.42)
HAstV 6 0 (0) 2 (2.99) 4 (7.27) 5 (25.00) 0 (0) 2 (11.11) 13 (6.95)
HAstV 8 0 (0) 8 (11.94) 5 (9.09) 2 (10.00) 1 (6.67) 2 (11.11) 18 (9.63)
aStatistically signiﬁcant (p <0.01) changes in the genotype distribution from year to year are shown in bold.
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FIG. 1. Phylogenetic tree of human astrovirus (HAstV) nucleotide sequences. Neighbour-joining phylogenetic tree based on nucleotide
sequences of the capsid region of the HAstV genome. The numbers in the branches indicate the bootstrap values. Reference strains of HAstV
selected from GenBank are indicated by accession numbers. The scale indicates nucleotide substitutions per position.
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[13]. All PCR products were sequenced using an ABI Prism
3100 automated sequencer and Big Dye Terminator Cycle
Sequencing Mix (Perkin Elmer, Wellesley, MA). The 348-bp
HAstV RT-PCR product was sequenced and compared to
reference strains by using BLAST software (National Center
for Biotechnology Information, Bethesda, MD, USA) to assign
a genotype. Multiple sequence alignments were calculated
using CLUSTAL X software [14], and, on the basis of different
HAstV sequences available from GenBank, a phylogenetic
analysis was conducted with MEGA, version 3.1 [15], using the
Neighbour-joining method.
We detected six genotypes of HAstV: 1, 2, 3, 4, 6 and
8. As shown in Table 1, HAstV-1 was the dominant geno-
type in every year investigated. The overall distribution of
the genotypes of the 187 HAstV strains detected in clinical
specimens and characterized was as: HAstV-1, 72.19%
(n = 135); HAstV-8, 9.63% (n = 18); HAstV-6, 6.95%
(n = 13); HAstV-4, 6.42% (n = 12); HAstV-2, 3.21% (n = 6);
and HAstV-3, 1.60% (n = 3). Previous studies have
reported that HAstV-1 is also the predominant HAstV
genotype in Egypt, Italy, France, China and Spain [8,11,16–
18]. However, our ﬁndings regarding the relative preva-
lence of other genotypes differ from some of these previ-
ous investigations [8,11]. In Mexico, the prevalence of
HAstV-1 was low (10%) compared to genotypes 2 (42%),
4 (23%), 3 (13%), 5 (6%) and 7 (6%) [19], and a recent
study in Madagascar reported a high prevalence of unusual
type 8 strains [20].
Phylogenetic analysis indicated that HAstV-1 strains could
be classiﬁed into four lineages (1a–1d), with the majority of
Korean HAstV strains clustered into lineage 1a (65.78%). In
2002, 91.67% of HAstV-1 strains were type 1a, although
this prevalence signiﬁcantly decreased from year to year,
reaching 33% in 2007 (p <0.01). Studies conducted in Spain,
Germany, Brazil, Vietnam, Japan and China have indicated
that HAstV-1d is the predominant type in these countries
[14]. In the present study, HAstV-1d was ﬁrst detected in
2003 and exhibited a peak prevalence of 26.67% in 2006.
Phylogenetic analysis was also used to evaluate the related-
ness of HAstV strains detected in the present study to ref-
erence strains (Fig. 1). Nucleotide comparison revealed that
Korean HAstV strains showed homology of 85.9–100% to
reference HAstV-1 isolates, 98.9–100% to HAstV-2 isolates,
93.1–99.7% to HAstV-3 isolates, 90.2–100% to HAstV-4 iso-
lates, 98.6–100% to HAstV-6 isolates and 98.6–100% to
HAstV-8 isolates. Homology between the Korean strains
and other HAstV strains in lineage 1a was in the range
92.5–100%.
This is the ﬁrst report on a large-scale nationwide surveil-
lance of the prevalence and molecular characterization of
HAstV strains circulating in Korea. The ﬁndings of the pres-
ent study clearly indicate that HAstV is less common but,
even so, a potentially important viral aetiological agent with
a signiﬁcant role in acute gastroenteritis in Korea. The nucle-
otide analysis data obtained in the present study regarding
the characteristics of HAstV strains may be valuable in the
development of a HAstV vaccine.
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